Pediatric acute lymphoblastic leukemia relapse and prognosis: key predictors and therapeutic implications
BackgroundPediatric acute lymphoblastic leukemia (ALL), the most common childhood malignancy, achieves >95% 5-year survival with risk-adapted therapies. Nonetheless, 10%–15% of patients experience relapse, with post-relapse survival <50%. Challenges remain in optimizing minimal residual diseas...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2025-12-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1710578/full |
| Tags: |
No Tags, Be the first to tag this record!
|